Hydrocodone Bitartrate and Acetaminophen (Page 6 of 6)

MEDICATION GUIDE

Hydrocodone Bitartrate (hye” droe koe’ done bye tar’ trate) and Acetaminophen (a seet”a min’ oh fen) Tablets USP, CII

Hydrocodone Bitartrate and Acetaminophen Tablets are:

  • A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain severe enough to require an opioid pain medicine, when other pain treatments such as non-opioid pain medicines do not treat your pain well enough or you cannot tolerate them.
  • An opioid pain medicine that can put you at risk for overdose and death. Even if you take your dose correctly as prescribed you are at risk for opioid addiction, abuse, and misuse that can lead to death.

Important information about Hydrocodone Bitartrate and Acetaminophen Tablets:

  • Get emergency help or call 911 right away if you take too much Hydrocodone Bitartrate and Acetaminophen Tablets (overdose). When you first start taking Hydrocodone Bitartrate and Acetaminophen Tablets, when your dose is changed, or if you take too much (overdose), serious or life-threatening breathing problems that can lead to death may occur. Talk to your healthcare provider about naloxone, a medicine for the emergency treatment of an opioid overdose.
  • Taking Hydrocodone Bitartrate and Acetaminophen Tablets with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.
  • Never give anyone else your Hydrocodone Bitartrate and Acetaminophen Tablets. They could die from taking it. Selling or giving away Hydrocodone Bitartrate and Acetaminophen Tablets is against the law.
  • Store Hydrocodone Bitartrate and Acetaminophen Tablets securely, out of sight and reach of children, and in a location not accessible by others, including visitors to the home.

Do not take Hydrocodone Bitartrate and Acetaminophen Tablets if you have:

  • severe asthma, trouble breathing, or other lung problems.
  • a bowel blockage or have narrowing of the stomach or intestines.
  • known hypersensitivity to hydrocodone or acetaminophen, or any ingredient in Hydrocodone Bitartrate and Acetaminophen Tablets

Before taking Hydrocodone Bitartrate and Acetaminophen Tablets, tell your healthcare provider if you have a history of:

  • head injury, seizures
  • liver, kidney, thyroid problems
  • problems urinating
  • pancreas or gallbladder problems
  • abuse of street or prescription drugs, alcohol addiction, opioid overdose, or mental health problems.

Tell your healthcare provider if you are:

  • noticing your pain getting worse. If your pain gets worse after you take Hydrocodone Bitartrate and Acetaminophen Tablets, do not take more of Hydrocodone Bitartrate and Acetaminophen Tablets without first talking to your healthcare provider. Talk to your healthcare provider if the pain that you have increases, if you feel more sensitive to pain, or if you have new pain after taking Hydrocodone Bitartrate and Acetaminophen Tablets.
  • Are pregnant or planning to become pregnant. Use of Hydrocodone Bitartrate and Acetaminophen Tablets for an extended period of time during pregnancy can cause withdrawal symptoms in your newborn baby that could be life-threatening if not recognized and treated.
  • breastfeeding. Hydrocodone bitartrate and acetaminophen passes into breast milk and may harm your baby.
  • living in a household where there are small children or someone who has abused street or prescription drugs.
  • taking prescription or over-the-counter medicines, vitamins, or herbal supplements. Taking Hydrocodone Bitartrate and Acetaminophen Tablets with certain other medicines can cause serious side effects that could lead to death.

When taking Hydrocodone Bitartrate and Acetaminophen Tablets:

  • Do not change your dose. Take Hydrocodone Bitartrate and Acetaminophen Tablets exactly as prescribed by your healthcare provider. Use the lowest dose possible for the shortest time needed.
  • For acute (short-term) pain, you may only need to take Hydrocodone Bitartrate and Acetaminophen Tablets for a few days. You may have some Hydrocodone Bitartrate and Acetaminophen Tablets left over that you did not use. See disposal information at the bottom of this section for directions on how to safely throw away (dispose of) your unused Hydrocodone Bitartrate and Acetaminophen Tablets.
  • Take your prescribed dose every four to six hours as needed for pain.
  • Do not take more than your prescribed dose. If you miss a dose, take your next dose at your usual time.
  • Call your healthcare provider if the dose you are taking does not control your pain.
  • If you have been taking Hydrocodone Bitartrate and Acetaminophen Tablets regularly, do not stop taking Hydrocodone Bitartrate and Acetaminophen Tablets without talking to your healthcare provider.
  • Dispose of expired, unwanted, or unused Hydrocodone Bitartrate and Acetaminophen Tablets by taking your drug to an authorized DEA-registered collector or drug take-back program. If one is not available, you can dispose of Hydrocodone Bitartrate and Acetaminophen Tablets by mixing the product with dirt, cat litter, or coffee grounds; placing the mixture in a sealed plastic bag, and throwing the bag in your trash. Visit www.fda.gov/drugdisposal for additional information on disposal of unused medicines.

While taking Hydrocodone Bitartrate and Acetaminophen Tablets DO NOT:

  • Drive or operate heavy machinery, until you know how Hydrocodone Bitartrate and Acetaminophen Tablets affect you. Hydrocodone Bitartrate and Acetaminophen Tablets can make you sleepy, dizzy, or lightheaded.
  • Drink alcohol or use prescription or over-the-counter medicines that contain alcohol. Using products containing alcohol during treatment with Hydrocodone Bitartrate and Acetaminophen Tablets may cause you to overdose and die.

The possible side effects of Hydrocodone Bitartrate and Acetaminophen Tablets:

  • constipation, nausea, sleepiness, vomiting, tiredness, headache, dizziness, abdominal pain. Call your healthcare provider if you have any of these symptoms and they are severe.

Get emergency medical help or call 911 right away if you have:

  • trouble breathing, shortness of breath, fast heartbeat, chest pain, swelling of your face, tongue, or throat, extreme drowsiness, light-headedness when changing positions, feeling faint, agitation, high body temperature, trouble walking, stiff muscles, or mental changes such as confusion.

These are not all the possible side effects of Hydrocodone Bitartrate and Acetaminophen Tablets. Call your healthcare provider for medical advice about side effects. You may report side effects to XLCare Pharmaceuticals Inc., at 1-866-495-1995 or FDA at 1-800-FDA-1088. For more information go to dailymed.nlm.nih.gov

Manufactured by:

Ascent Pharmaceuticals, Inc.

Central Islip, NY 11722

Manufactured for:

XLCare Pharmaceuticals, Inc.

242 South Culver Street, Suite 202

Lawrenceville, GA 30046

This Medication Guide has been approved by the U.S. Food and Drug Administration. Revised: 09/23

Hydrocodone Bitartrate and Acetaminophen Tablets 2.5 mg/325 mg — 100s count

2.5 mg-100
(click image for full-size original)
Hydrocodone Bitartrate and Acetaminophen Tablets 5 mg/325 mg — 100s count

5 mg-100
(click image for full-size original)
Hydrocodone Bitartrate and Acetaminophen Tablets 5 mg/325 mg — 500s count

5 mg-500
(click image for full-size original)
Hydrocodone Bitartrate and Acetaminophen Tablets 7.5 mg/325 mg — 100s count

7.5 mg-100
(click image for full-size original)
Hydrocodone Bitartrate and Acetaminophen Tablets 7.5 mg/325 mg — 500s count

7.5 mg-500
(click image for full-size original)
Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/325 mg — 100s count

10 mg-100
(click image for full-size original)
Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/325 mg — 500s count

10 mg-500
(click image for full-size original)
HYDROCODONE BITARTRATE AND ACETAMINOPHEN hydrocodone bitartrate and acetaminophen tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72865-201
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROCODONE BITARTRATE (HYDROCODONE) HYDROCODONE BITARTRATE 2.5 mg
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 325 mg
Inactive Ingredients
Ingredient Name Strength
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
CROSPOVIDONE
STARCH, PREGELATINIZED CORN
POVIDONE
STEARIC ACID
Product Characteristics
Color white (Off white to white) Score no score
Shape CAPSULE Size 13mm
Flavor Imprint Code T256
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72865-201-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA211487 02/27/2020
HYDROCODONE BITARTRATE AND ACETAMINOPHEN hydrocodone bitartrate and acetaminophen tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72865-202
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROCODONE BITARTRATE (HYDROCODONE) HYDROCODONE BITARTRATE 5 mg
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 325 mg
Inactive Ingredients
Ingredient Name Strength
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
CROSPOVIDONE
STARCH, PREGELATINIZED CORN
POVIDONE
STEARIC ACID
Product Characteristics
Color white (Off white to white) Score 2 pieces
Shape CAPSULE Size 13mm
Flavor Imprint Code T257
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72865-202-01 100 TABLET in 1 BOTTLE None
2 NDC:72865-202-05 500 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA211487 02/27/2020
HYDROCODONE BITARTRATE AND ACETAMINOPHEN hydrocodone bitartrate and acetaminophen tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72865-203
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROCODONE BITARTRATE (HYDROCODONE) HYDROCODONE BITARTRATE 7.5 mg
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 325 mg
Inactive Ingredients
Ingredient Name Strength
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
CROSPOVIDONE
STARCH, PREGELATINIZED CORN
POVIDONE
STEARIC ACID
Product Characteristics
Color white (Off white to white) Score 2 pieces
Shape CAPSULE Size 13mm
Flavor Imprint Code T258
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72865-203-01 100 TABLET in 1 BOTTLE None
2 NDC:72865-203-05 500 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA211487 02/27/2020
HYDROCODONE BITARTRATE AND ACETAMINOPHEN hydrocodone bitartrate and acetaminophen tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72865-204
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROCODONE BITARTRATE (HYDROCODONE) HYDROCODONE BITARTRATE 10 mg
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 325 mg
Inactive Ingredients
Ingredient Name Strength
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
CROSPOVIDONE
STARCH, PREGELATINIZED CORN
POVIDONE
STEARIC ACID
Product Characteristics
Color white (Off white to white) Score 2 pieces
Shape CAPSULE Size 13mm
Flavor Imprint Code T259
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72865-204-01 100 TABLET in 1 BOTTLE None
2 NDC:72865-204-05 500 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA211487 11/08/2018
Labeler — XLCare Pharmaceuticals, Inc. (080991142)
Establishment
Name Address ID/FEI Operations
Ascent Pharmaceuticals, Inc. 080938961 analysis (72865-201), analysis (72865-202), analysis (72865-203), analysis (72865-204), manufacture (72865-201), manufacture (72865-202), manufacture (72865-203), manufacture (72865-204), pack (72865-201), pack (72865-202), pack (72865-203), pack (72865-204)

Revised: 09/2023 XLCare Pharmaceuticals, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.